The goal of the University of Louisville Molecular Targets COBRE Core D is to facilitate the rapid translation of novel approaches to cancer prevention, diagnosis and treatment through the use of transgenic mouse models of cancer. In particular. Core D will facilitate the translational objectives of University of Louisville COBRE-related investigators by developing coordinated resources, techniques, expertise and several colonies of transgenic mice for the safety and efficacy testing of novel anti-cancer approaches. The initial goal will be to establish colonies of the transgenic mice and to develop methods for longitudinal monitoring of tumor progression or regression without the need to euthanize the animals. Once the core is established, the long-term objectives will be to provide access of transgenic mouse models of cancer to junior and senior cancer researchers at the University of Louisville, including past and present COBRE investigators, in order to facilitate the testing of novel anti-cancer compounds and strategies. The specific objectives are to: (i) Maintain, distribute and provide pre-clinical toxicity and efficacy support for transgenic mouse models of melanoma, childhood neuroblastoma, lung, breast, prostate, colon, pancreatic and hematological cancers;(ii) Provide technical support for transgenic mouse genotyping, specimen collection and processing, and PK analyses of novel anti-cancer agents;and (iii) Conduct state-of-the-art diagnostic imaging services for the detection of tumors and response to novel therapeutic agents. In summary, we propose a core facility that will procure and breed transgenic mouse models of several common cancer types and that will provide technical services to facilitate the testing of novel strategies and drugs developed at the University of Louisville.
Core E will support pre-clinical safety and efficacy trials of novel compounds and strategies to detect, prevent and treat cancer so that our COBRE investigators can rapidly move these agents and strategies from laboratory benches into cages and then phase I trials of human subjects suffering with cancer.
|Bardi, Gina T; Smith, Mary Ann; Hood, Joshua L (2018) Melanoma exosomes promote mixed M1 and M2 macrophage polarization. Cytokine 105:63-72|
|Neely, Aaron M; Zhao, Guoping; Schwarzer, Christian et al. (2018) N-(3-Oxo-acyl)-homoserine lactone induces apoptosis primarily through a mitochondrial pathway in fibroblasts. Cell Microbiol 20:|
|Ikeya, Teppei; Ban, David; Lee, Donghan et al. (2018) Solution NMR views of dynamical ordering of biomacromolecules. Biochim Biophys Acta Gen Subj 1862:287-306|
|Sabo, T Michael; Gapsys, Vytautas; Walter, Korvin F A et al. (2018) Utilizing dipole-dipole cross-correlated relaxation for the measurement of angles between pairs of opposing C?H?-C?H? bonds in anti-parallel ?-sheets. Methods 138-139:85-92|
|Hao, Jiaqing; Zhang, Yuwen; Yan, Xiaofang et al. (2018) Circulating Adipose Fatty Acid Binding Protein Is a New Link Underlying Obesity-Associated Breast/Mammary Tumor Development. Cell Metab 28:689-705.e5|
|Monsen, Robert C; Trent, John O (2018) G-quadruplex virtual drug screening: A review. Biochimie 152:134-148|
|Jones, Dominique Z; Schmidt, M Lee; Suman, Suman et al. (2018) Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells. BMC Cancer 18:421|
|Woo, Sangsoon; Gao, Hong; Henderson, David et al. (2017) AKR1C1 as a Biomarker for Differentiating the Biological Effects of Combustible from Non-Combustible Tobacco Products. Genes (Basel) 8:|
|Shukla, Devesh; Rinehart, Claire A; Sahi, Shivendra V (2017) Comprehensive study of excess phosphate response reveals ethylene mediated signaling that negatively regulates plant growth and development. Sci Rep 7:3074|
|Al-Eryani, Laila; Waigel, Sabine; Jala, Venkatakrishna et al. (2017) Cell cycle pathway dysregulation in human keratinocytes during chronic exposure to low arsenite. Toxicol Appl Pharmacol 331:130-134|
Showing the most recent 10 out of 55 publications